Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. OTC Markets
  5. H-CYTE, Inc.
  6. Company
    HCYT   US4041241096

H-CYTE, INC.

(HCYT)
  Report
SummaryQuotesChartsNewsCompanyFinancials 
Business Summary
H-CYTE, Inc., formerly Medovex Corp., is a development-stage company. The Company focuses on obtaining, developing and commercializing various intellectual property rights (patents, patent applications and knowhow) in the medical technology area, with particular focus on the development of medical devices. It focuses on the development and commercialization of the DenerveX System, which consists of the DenerveX Device and the DenerveX Pro-40 power generator (DenerveX). DenerveX is a device that is intended to be used in the treatment of conditions resulting from the degeneration of joints in the spine that cause back pain. The DenerveX Pro-40 Power Generator is the power source for the DenerveX System. The system works in synchronization to deliver controlled and precise therapy to patients with facet joint pain. DenerveX combines two procedures in one: capsular tissue removal through a light tissue scraping action and radio ablation denervation.

Number of employees : 26 people.
Sales per Business
20192020Delta
USD (in Million)%USD (in Million)%
Biosciences8.35100%2.15100% -74.23%
Sales per region
20192020Delta
USD (in Million)%USD (in Million)%
United States8.35100%2.15100% -74.23%
Managers
NameAgeSinceTitle
Robert Greif542020President & Chief Executive Officer
Jeremy Daniel43-Chief Financial & Accounting Officer
Tanya Rhodes, Dr.-2020Chief Technology Officer
Raymond Monteleone722021Chairman
Jason Assad--Investor Relations Contact
Members of the board
NameAgeSinceTitle
Raymond Monteleone722021Chairman
William E. Horne652021Director
Michael W. Yurkowsky462019Director
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 136,109,864 27,361,053 20.1% 0 0.0% 20.1%
Stock B 0 6,100 0 0.0% 0 0.0%
Shareholders
NameEquities%
Regenerative Medicine Solutions LLC 50,925,276 37.4%
William B. Horne 8,593,913 6.31%
Michael W. Yurkowsky 1,022,009 0.75%
Meridian Investment Counsel, Inc. 100,000 0.073%
Two Sigma Securities LLC 38,781 0.028%
Citadel Advisors LLC 29,298 0.022%
Fisher Asset Management LLC 27,500 0.020%
The Vanguard Group, Inc. 26,905 0.020%
Coastal Bridge Advisors LLC 25,000 0.018%
Millennium Management LLC 21,553 0.016%
Company contact information
H-Cyte, Inc.
201 East Kennedy Boulevard
Suite 700
Tampa, FL 33602

Phone : +1.844.633.6839
Web : http://www.hcyte.com
Sector Other Medical Equipment, Supplies & Distribution